Updated:
Friedman Bioventures
BioVentures MedTech Funds invests in companies developing leading-edge medical technologies. The firm focuses on emerging and growth stage MedTech companies...
Friedman Bioventures
BioVentures MedTech Funds invests in companies developing leading-edge medical technologies. The firm focuses on emerging and growth stage MedTech companies and plays an active role in portfolio company growth. Its team leverages industry experience, scientific and clinical backgrounds, regulatory knowledge, and financial acumen to select opportunities, develop companies, and exit.
General information
Firm type
Venture Capital
Year founded
2012
Location
Region
North America
Country
United States
City
San Diego
Corporate office
San Diego, CA, United States
Sector focus
Frequently asked questions
Which sectors does Friedman Bioventures focus on?
Friedman Bioventures invests in therapeutics, medical devices, diagnostics, and digital health (public record). The firm's portfolio companies generally have identified clinical needs and regulatory pathways.
Does Friedman Bioventures participate in fund commitments or only direct deals?
The firm primarily engages in direct equity investments and co-investments alongside other healthcare-focused venture funds (public record). It does not publicly disclose commitments to third-party fund vehicles.
Who runs investment decisions at Friedman Bioventures?
The firm does not publicly identify its investment team or leadership on its website or in public records. No named principals or professionals are available from disclosed sources.
Profile maintained by Altss using OSINT (open-source intelligence), regulatory filings, licensed data partners, and verified direct submissions. Read the methodology. Last updated: . Continuous refresh with full update cycles at least every 30 days.
Need institutional-grade insight on venture capital firms?
Altss delivers:
Prefer a guided tour?
We’ll walk you through: